visible-on: Access Campaign
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
MSF warns governments are failing to test, treat and prevent TB in children
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
